COVID-19: A Catalyst for Change for UK Clinical Oncology.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Coles, Charlotte Elizabeth
Choudhury, Ananya
Hoskin, Peter J
Jones, Christopher M
O'Leary, Ben
Abstract
The United Kingdom has been severely affected by the coronavirus disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritized management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education, and research, providing a legacy that will extend well beyond the pandemic that catalyzed them. This editorial focuses on 3 key themes that distinguish the United Kingdom from many other countries.
Description
Keywords
5105 Medical and Biological Physics, 32 Biomedical and Clinical Sciences, 34 Chemical Sciences, 3407 Theoretical and Computational Chemistry, 51 Physical Sciences, 3211 Oncology and Carcinogenesis
Journal Title
Int J Radiat Oncol Biol Phys
Conference Name
Journal ISSN
0360-3016
1879-355X
1879-355X
Volume Title
108
Publisher
Elsevier BV
Publisher DOI
Rights
All rights reserved